GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: IFN-alpha-2 | interferon alpha-2 | Roferon A®
IFN-α2 is an approved drug (FDA (1989))
Compound class:
Endogenous peptide in human, mouse or rat
Comment: IFN-α2 is a type I IFN. The sequence of the recombinant peptide used clinically and known as interferon alfa-2a, is identical to that of human IFN-α2. Interferon α-2a has anti-viral, immunomodulatory and antineoplastic actions.
Pegylated IFN-α-2a is on the World Health Organization's List of Essential Medicines.
Species: Human
|
Classification ![]() |
|
| Compound class | Endogenous peptide in human, mouse or rat |
| Ligand families/groups | Interferons |
| Approved drug? | Yes. US FDA (1989) |
Synonyms ![]() |
| IFN-alpha-2 | interferon alpha-2 | Roferon A® |
Gene/Precursor ![]() |
||||||||||
|
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 624 |
| Other databases | |
| Ensembl Gene | ENSG00000188379 (Hs) |
| GtoPdb PubChem SID | 178101658 |
| Human Protein Atlas | ENSG00000188379 (Hs) |
| UniProtKB | P01563 (Hs) |
| Wikipedia | IFNA2 |